In addition, PDE5 inhibitors have been seen to improve left ventricular functional and structural parameters in humans with HF, and to exhibit cardioprotective activity against left ventricular remodeling, as demonstrated by several animal models of pressure-overload HF [4–8]. Here, PDE5A is linked to hydrops fetalis.